C. Gobbi

Amyloid detection and typing yield of skin biopsy in systemic amyloidosis and polyneuropathy

G. Melli, Elena Vacchi, A. Tzankov, 2023, Annals of clinical and translational neurology.

Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis.

S. Pluchino, E. Pravatà, L. Peruzzotti-Jametti, 2023, Cell stem cell.

Motor and sensory responses after percutaneous tibial nerve stimulation in multiple sclerosis patients with lower urinary tract symptoms treated in daily practice

C. Zecca, G. Digesu, F. Puccini, 2014, European journal of neurology.

Specific Aspects of Immunotherapy for Multiple Sclerosis in Switzerland—A Structured Commentary, Update 2022

A. Salmen, L. Achtnichts, C. Pot, 2022, Clinical and Translational Neuroscience.

Effectiveness, Safety and Patients’ Satisfaction of Nabiximols (Sativex®) on Multiple Sclerosis Spasticity and Related Symptoms in a Swiss Multicenter Study

G. Riccitelli, G. Disanto, R. Sacco, 2024, Journal of clinical medicine.

Recommendations for the Treatment of Multiple Sclerosis in Family Planning, Pregnancy and Lactation in Switzerland: Immunotherapy

I. Jelcic, A. Salmen, R. Hoepner, 2024, Clinical and Translational Neuroscience.

Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies

J. Lechner-Scott, M. Slee, A. Ponsonby, 2023, Journal of neurology.

Self-reports by persons with multiple sclerosis are an adequate surrogate for healthcare provider data on disease-modifying therapy and multiple sclerosis type

Zina-Mary Manjaly, V. Ajdacic-Gross, Ö. Yaldizli, 2023, Multiple Sclerosis and Related Disorders.